Regulus Therapeutics
RGLS
#7200
Rank
A$0.85 B
Marketcap
A$12.33
Share price
0.00%
Change (1 day)
423.09%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): A-$1.12

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.10. In 2024 the company made an earnings per share (EPS) of A-$1.31.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$1.12-14.77%
2024A-$1.31
2022A-$2.81-43.12%
2021A-$4.94-40.55%
2020A-$8.31-50%
2019A-$16.62-80.36%
2018A-$84.60-57.8%
2017A-$200.48-28.66%
2016A-$281.0142.2%
2015A-$197.61-14.84%
2014A-$232.06156%
2013A-$90.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.99-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$3.57-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.83-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.76-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$4.35-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A-$0.57-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.93-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA